CN101391088A - Enterogastritis oral medicine - Google Patents

Abstract

The invention relates to oral medicine for treating gastroenteritis, which belongs to the technical field of medicine. The oral medicine comprises the following active compositions in weight: 0.14 to 0.27 portions of atractylodes, 0.08 to 0.16 portions of magnolia officinalis, 0.2 to 0.4 portions of white paeony root fried with wine, 0.14 to 0.27 portions of safflower, 0.16 to 0.32 portions of rhizome corydalis, 0.14 to 0.27 portions of bitter orange, 0.28 to 0.52 portions of fructus evodiae, 0.16 to 0.32 portions of astragalus, 0.30 to 0.60 portions of cinnamon, 1.6 to 3.0 portions of fried lanceolata, 1.6 to 3.0 portions of fried atractylodes, 0.62 to 1.22 portions of dried ginger, 0.72 to 1.55 portions of amomum, 1.6 to 3.0 portions of fried yam, 1.6 to 3.0 portions of fried euryale ferox and 1.6 to 3.0 portions of cuttlefish bone. The invention is made from pure Chinese traditional medicine, can alleviate symptoms and treat primary causes, and has less side effects and significant curative effect.

Description

Enterogastritis oral medicine

Technical field

The present invention relates to a kind of enterogastritis oral medicine, belong to technical field of pharmaceuticals.

Background technology

Decades so far, suffer from the patients having chronic intestinal inflammation obstinate, cause the patient painful every year, the western medicine and medical practitioners treatment is because of can't the repairing ulcer face reaching reasons such as destruction to the intestinal beneficial bacterium group, imbalance, cause real healing person very few, it is imperative to seek the traditional Chinese medical herbal treatment chronic enteritis.

Summary of the invention

The object of the present invention is to provide a kind of enterogastritis oral medicine, pure Chinese medicine is formed, and takes stopgap measures and effects a permanent cure, and toxic and side effects is little, and therapeutic effect is good.

Enterogastritis oral medicine of the present invention, its active component weight consists of:

1.6～3.0 parts of 0.14～0.27 part of Rhizoma Atractylodis, 0.08～0.16 part of Cortex Magnoliae Officinalis, 0.2～0.4 part of Radix Paeoniae Alba (parched with wine), 0.14～0.27 part on Flos Carthami, 0.16～0.32 part of Rhizoma Corydalis, 0.14～0.27 part of Fructus Aurantii, 0.28～0.52 part of Fructus Evodiae, 0.16～0.32 part of the Radix Astragali, 0.30～0.60 part of Cortex Cinnamomi, 1.6～3.0 parts of Radix Codonopsis (parched), 1.6～3.0 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 0.62～1.22 part of Rhizoma Zingiberis, 0.72～1.55 part of Fructus Amomi, 1.6～3.0 parts of Rhizoma dioscoreae (parched)s, 1.6～3.0 parts of Semen Euryales (parched) and Os Sepiae.

Best group becomes:

2.3 parts of 0.2 part of Rhizoma Atractylodis, 0.12 part of Cortex Magnoliae Officinalis, 0.3 part of Radix Paeoniae Alba (parched with wine), 0.2 part on Flos Carthami, 0.24 part of Rhizoma Corydalis, 0.2 part of Fructus Aurantii, 0.4 part of Fructus Evodiae, 0.24 part of the Radix Astragali, 0.46 part of Cortex Cinnamomi, 2.3 parts of Radix Codonopsis (parched), 2.3 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 0.92 part of Rhizoma Zingiberis, 1.15 parts of Fructus Amomis, 2.3 parts of Rhizoma dioscoreae (parched)s, 2.3 parts of Semen Euryales (parched) and Os Sepiae.

15.93 the total amount of gram is ground to fine powder and is made electuary for dose of adult every day twice, directly takes after mixing it with water.Packing is preserved under the aseptic condition of sterilization back.

Can stay each a part of fine powder mixing of Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Semen Euryales, Os Sepiae to do absorbent, surplus and other medicines boil concentration and contract afterwards and the absorbent mixing, make electuary under oven dry, sterilization, the aseptic condition, each 4～6g that is grown up (containing former medicine 15.93g prescription drugs), twice of every day is oral.Also can add excipient and make pill or tablets and other formulations medicine, take for twice every day by the pharmaceutical technology flow process.

Effect and effect: antiinflammatory, pain relieving, the kidney invigorating, stomach warming, spleen invigorating, astringing intestine to stop diarrhea, control adaptive colitis, remove gastrointestinal dysfunction, improve digestive and absorptive functions, the protection intestinal mucosa is repaired gastroenteritic ulcer face focus.

Indication: to chronic ulcerative colitis, chronic stomach cold gastritis, allergic colitis, chronic digestible malabsorption diarrhoea, the cold and cool property of gastrointestinal diarrhoea, chronic diarrhea before dawn, gastrointestinal dysfunction diarrhoea and crampy gastrointestinal pain etc.

Enterogastritis oral medicine of the present invention, pure Chinese medicine is formed, have no side effect, take stopgap measures and effect a permanent cure, therapeutic effect is good, and through clinical treatment confirmation for many years, effective percentage reaches 100%, cured nearly thousand examples of patient, the cure rate of ulcerative colitis, stomach cold gastritis (do not comprise contain the helicobacter pylori infections person), allergic colitis has been reached 98%; Chronic gastrointestinal dysfunction diarrhoea, gastrointestinal dyspepsia diarrhoea cure rate are reached more than 95%; Gastrointestinal convulsion stomachache, diarrhea before dawn cure rate are reached more than 90%.

The clinical model case of practical application is as follows:

Example 1, name: Li Jiaquan, sex: the man, the age: 55 years old, address: crossdrift village, villages and small towns, Shandong, Yiyuan County, Zibo City, Shandong Province; Consultation time: on May 18th, 2003.The condition at that time of going to a doctor: the medical history in existing more than 20 year so far that the patient suffers from chronic enterogastritis, the painful diarrhoea of abdomen every day since ill, stool every day 3-5 time, more serious after the food raw food, many western medicine results are not remarkable with crossing, and patient's bodily form is become thin when examining, dim complexion, tongue is white, weak pulse is unable, is diagnosed as stomach cold gastritis and chronic ulcerative colitis.Medication process and effect: took medicine for enterogastritis the same day, 3 days painful alleviating of venter posterior, times of defecation is reduced to 2 times, obeys 7 days basic recoveries again and normally consolidates and took medicine 10 days, thoroughly rehabilitation.Patient's readme is not recurrence so far.

Example 2, name: Liu Linyuan, sex: the man, the age: 20 years old, address: people from Boshan District of Zibo City, Shandong Province; Consultation time: October 23 calendar year 2001.The condition at that time of going to a doctor: the season of patient's weather sweltering heat, crapulence cold water, eating and drinking without temperance undermines the intestines and stomach, and frequent diarrhoea does not just later on wait for 2-6 time every day, if suffer from cold slightly or product that edible oil is greasy, the increased frequency of then suffering from diarrhoea, very then inferior surplus every day 10.Abdominal part often has sense of discomfort, and lower abdomen is latent painful, abdominal swelling, and once how tame examination in hospital, it is all undesirable to be diagnosed as " allergic colitis " therapeutic effect.Symptom aggravation when examining, outbreak is listless repeatedly.Medication process and effect: after last medicine for enterogastritis was taken 2 days, diarrhoea was promptly ended, and abdominal swelling disappears, and appended and took medicine 15 days, thoroughly cured.Follow up a case by regular visits to not recurrence after half a year

Example 3, name: Xu Hai, sex: the man, the age: 29 years old, address: Laiwu City Xin Zhuan town, Shandong Province Shi Wanzi; Consultation time: on August 12nd, 2005.The condition at that time of going to a doctor: this person is ready because of work, and eating and drinking without temperance is defecated and do not wait for 5-7 time every day, cold aggravation when forgiving, and morning, it was not bright painful and wake up with regard to abdomen.It is more anxious to suffer from diarrhoea, and abdomen is painful after an action of the bowels alleviates, and just rare mucus that is added with is diagnosed as cold and cool colitis of the intestines and stomach and diarrhea before dawn.Medication process and effect: serve on 15 doses with this medicine for enterogastritis, thoroughly cure.Follow up a case by regular visits to, so far not recurrence.

The specific embodiment

The invention will be further described below in conjunction with embodiment.

Embodiment 1

Enterogastritis oral medicine of the present invention, powder, its active component weight consists of:

Rhizoma Atractylodis 0.2 gram, Cortex Magnoliae Officinalis 0.12 gram, Radix Paeoniae Alba (parched with wine) 0.3 gram, Flos Carthami 0.2 gram, Rhizoma Corydalis 0.24 gram, Fructus Aurantii 0.2 gram, Fructus Evodiae 0.4 gram, the Radix Astragali 0.24 gram, Cortex Cinnamomi 0.46 gram, Radix Codonopsis (parched) 2.3 grams, Rhizoma Atractylodis Macrocephalae (parched) 2.3 grams, Rhizoma Zingiberis 0.92 gram, Fructus Amomi 1.15 grams, Rhizoma dioscoreae (parched) 2.3 grams, Semen Euryales (parched) 2.3 grams and Os Sepiae 2.3 grams.

Embodiment 2

Enterogastritis oral medicine of the present invention, electuary, its active component weight consists of:

Rhizoma Atractylodis 0.16 gram, Cortex Magnoliae Officinalis 0.13 gram, Radix Paeoniae Alba (parched with wine) 0.3 gram, Flos Carthami 0.16 gram, Rhizoma Corydalis 0.20 gram, Fructus Aurantii 0.19 gram, Fructus Evodiae 0.38 gram, the Radix Astragali 0.22 gram, Cortex Cinnamomi 0.50 gram, Radix Codonopsis (parched) 2.6 grams, Rhizoma Atractylodis Macrocephalae (parched) 1.9 grams, Rhizoma Zingiberis 0.82 gram, Fructus Amomi 0.92 gram, Rhizoma dioscoreae (parched) 1.8 grams, Semen Euryales (parched) 2.0 grams and Os Sepiae 2.2 grams.

Embodiment 3

Enterogastritis oral medicine of the present invention, pill, its active component weight consists of:

Rhizoma Atractylodis 0.23 gram, Cortex Magnoliae Officinalis 0.10 gram, Radix Paeoniae Alba (parched with wine) 0.26 gram, Flos Carthami 0.22 gram, Rhizoma Corydalis 0.23 gram, Fructus Aurantii 0.24 gram, Fructus Evodiae 0.39 gram, the Radix Astragali 0.32 gram, Cortex Cinnamomi 0.60 gram, Radix Codonopsis (parched) 3.0 grams, Rhizoma Atractylodis Macrocephalae (parched) 1.6 grams, Rhizoma Zingiberis 0.72 gram, Fructus Amomi 1.35 grams, Rhizoma dioscoreae (parched) 2.6 grams, Semen Euryales (parched) 1.8 grams and Os Sepiae 2.0 grams.

Embodiment 4

Enterogastritis oral medicine of the present invention, tablet, its active component weight consists of:

Rhizoma Atractylodis 0.20 gram, Cortex Magnoliae Officinalis 0.09 gram, Radix Paeoniae Alba (parched with wine) 0.35 gram, Flos Carthami 0.24 gram, Rhizoma Corydalis 0.3 gram, Fructus Aurantii 0.19 gram, Fructus Evodiae 0.44 gram, the Radix Astragali 0.23 gram, Cortex Cinnamomi 0.45 gram, Radix Codonopsis (parched) 2.8 grams, Rhizoma Atractylodis Macrocephalae (parched) 2.4 grams, Rhizoma Zingiberis 0.90 gram, Fructus Amomi 1.20 grams, Rhizoma dioscoreae (parched) 2.1 grams, Semen Euryales (parched) 2.5 grams and Os Sepiae 2.2 grams.

Embodiment 5

Enterogastritis oral medicine of the present invention, electuary, its active component weight consists of:

Rhizoma Atractylodis 0.20 gram, Cortex Magnoliae Officinalis 0.11 gram, Radix Paeoniae Alba (parched with wine) 0.3 gram, Flos Carthami 0.18 gram, Rhizoma Corydalis 0.26 gram, Fructus Aurantii 0.19 gram, Fructus Evodiae 0.33 gram, the Radix Astragali 0.22 gram, Cortex Cinnamomi 0.55 gram, Radix Codonopsis (parched) 1.9 grams, Rhizoma Atractylodis Macrocephalae (parched) 1.7 grams, Rhizoma Zingiberis 0.70 gram, Fructus Amomi 1.2 grams, Rhizoma dioscoreae (parched) 2.0 grams, Semen Euryales (parched) 2.3 grams and Os Sepiae 2.7 grams.

Claims (2)

1, a kind of enterogastritis oral medicine is characterized in that its active component weight consists of:

1.6～3.0 parts of 0.14～0.27 part of Rhizoma Atractylodis, 0.08～0.16 part of Cortex Magnoliae Officinalis, 0.2～0.4 part of Radix Paeoniae Alba (parched with wine), 0.14～0.27 part on Flos Carthami, 0.16～0.32 part of Rhizoma Corydalis, 0.14～0.27 part of Fructus Aurantii, 0.28～0.52 part of Fructus Evodiae, 0.16～0.32 part of the Radix Astragali, 0.30～0.60 part of Cortex Cinnamomi, 1.6～3.0 parts of Radix Codonopsis (parched), 1.6～3.0 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 0.62～1.22 part of Rhizoma Zingiberis, 0.72～1.55 part of Fructus Amomi, 1.6～3.0 parts of Rhizoma dioscoreae (parched)s, 1.6～3.0 parts of Semen Euryales (parched) and Os Sepiae.

2, enterogastritis oral medicine according to claim 1 is characterized in that its active component weight consists of:

2.3 parts of 0.2 part of Rhizoma Atractylodis, 0.12 part of Cortex Magnoliae Officinalis, 0.3 part of Radix Paeoniae Alba (parched with wine), 0.2 part on Flos Carthami, 0.24 part of Rhizoma Corydalis, 0.2 part of Fructus Aurantii, 0.4 part of Fructus Evodiae, 0.24 part of the Radix Astragali, 0.46 part of Cortex Cinnamomi, 2.3 parts of Radix Codonopsis (parched), 2.3 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 0.92 part of Rhizoma Zingiberis, 1.15 parts of Fructus Amomis, 2.3 parts of Rhizoma dioscoreae (parched)s, 2.3 parts of Semen Euryales (parched) and Os Sepiae.